Recruiting
Phase 3

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Sponsor:

T. John Winhusen, PhD

Code:

NCT03911739

Conditions

Opioid-Related Disorders

Drug Addiction

Pregnancy Related

Substance Abuse

Drug Abuse

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Buprenorphine Injection

Buprenorphine Sublingual Product

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information